Aslan Pharmaceuticals Ltd ADR (ASLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASLN | BMY | AMGN | GILD | REGN |
| Company | Aslan Pharmaceuticals Ltd ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6300 | 49.89 | 337.03 | 84.39 | 1,149.66 |
| High | 0.7000 | 50.04 | 338.70 | 84.65 | 1,165.85 |
| Low | 0.6000 | 49.11 | 334.61 | 83.57 | 1,148.13 |
| Last | 0.6000 | 49.40 | 337.10 | 84.58 | 1,158.88 |
| Change | -0.0999 | -0.34 | +4.18 | +0.69 | +20.07 |
| % Change | -14.27% | -0.68% | +1.26% | +0.82% | +1.76% |
| Volume | 806,300 | 3,023,657 | 605,864 | 3,483,199 | 302,424 |
| 20-Day Average Volume | 289,117 | 8,313,873 | 1,708,644 | 6,418,723 | 405,407 |
| Previous Close | 0.6999 | 49.74 | 332.92 | 83.89 | 1,138.81 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.0725 | 49.11 | 329.63 | 80.10 | 1,165.92 |
| 20-Day Raw Stochastic | 5.23% | 63.63% | 89.40% | 95.28% | 46.11% |
| 20-Day Relative Strength | 25.90% | 55.66% | 58.35% | 72.89% | 54.63% |
| Weighted Alpha | -93.79 | -10.39 | +27.58 | +19.29 | +42.52 |
| Today's Opinion | 100% Sell | 72% Buy | 96% Buy | 88% Buy | 80% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 80% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -75.71% since 07/11/24 | +2.29% since 09/12/24 | +2.07% since 09/12/24 | +1.54% since 09/12/24 | -0.52% since 09/12/24 |
| Low | 0.4750 on 07/17/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 1,134.59 on 09/17/24 |
| High | 2.7314 on 07/12/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | -75.97% since 06/18/24 | +0.09% since 08/19/24 | +2.72% since 08/19/24 | +13.42% since 08/19/24 | -3.21% since 08/19/24 |
| Low | 0.4750 on 07/17/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 1,113.24 on 09/11/24 |
| High | 2.8640 on 06/21/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | -86.11% since 04/18/24 | +20.91% since 06/18/24 | +10.10% since 06/18/24 | +33.71% since 06/18/24 | +11.48% since 06/18/24 |
| Low | 0.4750 on 07/17/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 1,011.67 on 07/03/24 |
| High | 4.8968 on 04/22/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | -85.84% since 01/18/24 | -4.74% since 03/19/24 | +23.98% since 03/19/24 | +15.03% since 03/19/24 | +20.21% since 03/19/24 |
| Low | 0.4750 on 07/17/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 875.22 on 04/26/24 |
| High | 16.7200 on 03/12/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,226 | 100,827,960 | 178,589,936 | 104,514,608 | 125,480,912 |
| Shares Outstanding, K | 2,044 | 2,027,100 | 536,435 | 1,245,853 | 110,186 |
| Annual Sales | 12,000,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -44,220,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 12,201,000,000 | 8,388,000,000 | 6,954,000,000 | 3,547,100,000 |
| Last Quarter Net Income | -9,920,000 | 1,680,000,000 | 746,000,000 | 1,614,000,000 | 1,432,300,000 |
| 60-Month Beta | 1.40 | 0.46 | 0.61 | 0.18 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | -10.32 on 05/09/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 08/09/24 | 10/31/24 | 10/29/24 | 11/05/24 | 11/07/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 17.67 | 29.85 |